受强制性开放获取政策约束的文章 - Rezvan Yazdian-Robati了解详情
无法在其他位置公开访问的文章：2 篇
Recent advances in nanotechnology-based drug delivery systems for the kidney
F Oroojalian, F Charbgoo, M Hashemi, A Amani, R Yazdian-Robati, ...
Journal of controlled release 321, 442-462, 2020
强制性开放获取政策： US National Institutes of Health
Phage-based nanomedicines as new immune therapeutic agents for breast cancer
A Arab, RY Robati, J Nicastro, R Slavcev, J Behravan
Current Pharmaceutical Design 24 (11), 1195-1203, 2018
强制性开放获取政策： Natural Sciences and Engineering Research Council of Canada
可在其他位置公开访问的文章：1 篇
CD44-specific short peptide A6 boosts cellular uptake and anticancer efficacy of PEGylated liposomal doxorubicin in vitro and in vivo
R Yazdian-Robati, E Amiri, H Kamali, A Khosravi, SM Taghdisi, ...
Cancer Nanotechnology 14 (1), 84, 2023
强制性开放获取政策： UK Medical Research Council
出版信息和资助信息由计算机程序自动确定